Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Royalty Pharma plc - Class A Ordinary Shares
(NQ:
RPRX
)
56.77
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,320
Open
56.77
Bid (Size)
56.50 (1,000)
Ask (Size)
57.50 (100)
Prev. Close
56.77
Today's Range
56.77 - 56.77
52wk Range
34.08 - 60.44
Shares Outstanding
388,132,400
Dividend Yield
1.66%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Royalty Pharma Q2 Earnings Call Highlights
↗
August 05, 2026
Royalty Pharma (NASDAQ:RPRX) raised its 2026 outlook for the second consecutive quarter after reporting higher second-quarter royalty receipts, continued capital deployment and progress across its...
Via
MarketBeat
Topics
Earnings
Royalty Pharma (NASDAQ:RPRX) Beats Q2 Revenue Estimates, Raises Full-Year Guidance
↗
August 05, 2026
Via
Chartmill
Performance
YTD
+46.1%
+46.1%
1 Month
+0.6%
+0.6%
3 Month
+9.9%
+9.9%
6 Month
+28.9%
+28.9%
1 Year
+56.8%
+56.8%
More News
Read More
Royalty Pharma reports second quarter 2026 results
August 05, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives
August 03, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
July 22, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma (NASDAQ:RPRX) Beats Q1 Estimates and Raises Guidance, Fueling Strong Momentum
↗
May 06, 2026
Via
Chartmill
Royalty Pharma declares third quarter 2026 dividend
July 17, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026
July 15, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)
June 14, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Unpopular Stocks We’re Skeptical Of
June 12, 2026
Via
StockStory
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings?
June 09, 2026
Via
StockStory
Topics
Supply Chain
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 04, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Mattel Stock Is Down 24%. Here's What a $50.9 Million Exit Could Mean
↗
May 29, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Royalty Pharma’s Q1 Earnings Call: Our Top 5 Analyst Questions
May 13, 2026
Via
StockStory
Topics
Earnings
Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally
↗
May 10, 2026
Via
The Motley Fool
This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge
↗
May 08, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Supply Chain
Royalty Pharma to present at upcoming investor conferences
May 07, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma (RPRX) Q1 2026 Earnings Transcript
↗
May 06, 2026
Via
The Motley Fool
Royalty Pharma reports first quarter 2026 results
May 06, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings
May 04, 2026
Via
StockStory
Topics
Artificial Intelligence
3 Unpopular Stocks We’re Skeptical Of
April 22, 2026
Via
StockStory
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
April 21, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma Declares Second Quarter 2026 Dividend
April 17, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
April 15, 2026
From
Royalty Pharma plc
Via
GlobeNewswire
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
April 10, 2026
Via
StockStory
Frequently Asked Questions
Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 56.77
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 08/07/26 04:00 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 22.03B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 22B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.